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INTRODUCTION:  Primary  neuroendocrine  tumors  (NET)  of the  extrahepatic  biliary  tree  are  a rare  entity
with  less  than  100  reported  cases  in  the  literature.
PRESENTATION  OF  CASE:  Here,  we  report  a case  of  NET  of  the  extrahepatic  bile  duct  in a 64-year-old
male  patient  presenting  with  painless  jaundice,  direct  hyperbilirubinemia,  and  mildly  elevated  transam-
inases.  Diagnostic  workup  with  an ultrasound  revealed  dilation  of the  intrahepatic  biliary  ducts,  without
cholelithiasis  or  choledocholithiasis.  Additional  cross  sectional  imaging  identiﬁed  a  stricture  at  the  con-
ﬂuence  of the  common  hepatic  and  cystic duct  junction.  Given  lack  of additional  ﬁndings  presumptive
diagnosis of  localized  klatskin’s  tumor  was  made.  The  patient  subsequently  underwent  resection  of  the
common  bile  duct  and  roux-en-y  hepaticojejunostomy  reconstruction.  Final  pathologic  diagnosis  showed
G2 well-differentiated  NET  of the  extrahepatic  bile  duct,  measuring  1.3 ×  1.1 × 1 cm.
DISCUSSION:  When  a patient  is  evaluated  for a primary  bile  duct  neoplasm,  differentiation  betweennusual biliary tumors cholangiocarcinoma  and  an  unusual  bile  duct  tumor,  such  as a NET  is  very  difﬁcult  before  surgical
resection  and  histologic  review.
CONCLUSION:  NET  of the extrahepatic  biliary  tree  are  a rare  entity.  Typical  presentation  is  with  painless
jaundice  and  other  symptoms  related  to  obstruction  of  the  biliary  tree  and  the  diagnosis  is usually  made
post-operatively.
© 2016  Published  by Elsevier  Ltd on  behalf  of  IJS Publishing  Group  Ltd.  This  is  an  open  access  article
under  the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Neuroendocrine tumors (NETs) are thought to originate from
nterochromafﬁn, or Kulchitsky cells, of the gastroenteropan-
reatic tract. These cells presumably undergo a pre-malignant
ntestinal metaplasia from inﬂammation. Enterochromafﬁn cells
re found in highest proportion in the small intestine, and
arely within the biliary ducts. This low proportion of precursor
ells corresponds with the low incidence of extrahepatic biliary
euroendocrine tumors (NET) [1,2,9]. The presenting signs and
ymptoms of extrahepatic NETs are secondary to the obstruction
f the normal ﬂow of bile, thereby causing hyperbilirubinemia and
aundice. Here we report case of a patient with extrahepatic NET in
ine with the SCARE criteria [3].∗ Corresponding author.
E-mail address: dr.farazali@gmail.com (F.A. Khan).
ttp://dx.doi.org/10.1016/j.ijscr.2016.11.043
210-2612/© 2016 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This i
rg/licenses/by-nc-nd/4.0/).2. Presentation of case
64-year-old male presented with 2-week history of jaundice,
pruritus, acholic stools, and tea colored urine. He also noted poor
oral intake and approximately 16-pound weight loss during that
time. He denied any abdominal pain, nausea, or vomiting and had
no family history of hepatopancreatobiliary malignancy. On exam-
ination, the patient’s skin was jaundiced, his abdomen was soft,
non-tender, non-distended and no masses were palpable. Labora-
tory test were suggestive of obstructive jaundice with Total and
Direct Bilirubin elevated at 1.6 and 1.1 mg/dL respectively. Right
upper quadrant ultrasound showed dilation of the intrahepatic bil-
iary ducts, without cholelithiasis or choledocholithiasis. The patient
subsequently underwent computerized tomography (CT) scan of
the abdomen and pelvis with intravenous and oral contrast, which
showed diffuse mild to moderate intrahepatic biliary ductal dilata-
tion, with a distended gallbladder. The common bile duct (CBD) at
the level of the gallbladder measured 1.4 cm,  with a distal abrupt
caliber change and a soft tissue density mass measuring 1.3 cm
was noted in the hepatic duct (Fig. 1). These ﬁndings were consid-
ered concerning for a Klatskin tumor/cholangiocarcinoma, without
s an open access article under the CC BY-NC-ND license (http://creativecommons.
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cig. 1. CT scan demonstrating distal abrupt caliber change and a soft tissue density
ass measuring 1.3 cm was noted in the hepatic duct.vidence of lymphadenopathy or metastasis. Magnetic resonance
holangiopancreatography (MRCP) validated the same ﬁndings.
ig. 2. A: Histologic ﬁndings of the gallbladder neoplasm: Tumor cells arranged in a t
osin  (HE), ×10); B. The tumors cells showed medium to large hyperchromatic nuclei wi
ytoplasm, and scattered mitotic ﬁgures (HE, ×40); C: The tumor cells were strongly positPEN  ACCESS
rgery Case Reports 30 (2017) 46–49 47
Moreover Carbohydrate antigen 19-9 (CA 19-9) was  checked and
found to be elevated at 50 U/mL.
The patient was  then referred to the Department of Surgical
Oncology at a teaching hospital and offered surgical resection.
The patient underwent resection of the CBD, cholecystectomy,
end to side roux-en-y hepaticojejunostomy, and portal lym-
phadenectomy, with a presumed pre-operative diagnosis of hilar
cholangiocarcinoma. Intraoperative frozen sections of resection
margins were negative for tumor. Dissected lymph nodes in the
porta hepatis were normal appearing. The patient’s immediate
postoperative course was uncomplicated and he was discharged
home on POD 4. The ﬁnal pathologic results showed a G2 neuroen-
docrine tumor of the extrahepatic CBD, measuring 1.3 × 1.1 × 1 cm
(Fig. 3). Histologically, the tumors cells were well differentiated
(Fig. 2A) with 13–15 mitoses per 10 high power ﬁelds (Fig. 2B).
The tumor showed perineural invasion but was  negative for lym-
phovascular invasion. Immunohistochemical staining showed all
the tumor cells were strongly positive for chromogranin, synap-
tophysin (Fig. 2C), and CD 56. Immunohistochemistry for Ki-67
showed a proliferation index of approximately 5 (Fig. 2D). The
histologic ﬁndings and the immunoproﬁle of the neoplasm were
consistent with neuroendocrine tumor, well differentiated, G2
(grade 2). Given the rarity of the clinical diagnosis verbal informed
consent was obtained from the patient to publish this case in a
scientiﬁc journal.3. Discussion
Less than 100 cases of extrahepatic biliary NET have been
reported in the literature to date. A review of the recent literature
rabecular pattern with scant intervening ﬁbrovascular stroma (Hematoxylin and
th coarse granular chromatin, occasional nucleoli, small to moderate amphophillic
ive for synaptophysin (×40); D: 5% of the tumor cells were positive for Ki-67 (×10).
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neuroendocrine tumor in a patient undergoing a mini gastric bypass: pointsig. 3. Macroscopic photograph of the cut surface of the lesion with arrow depicting
he  lesion.
howed that in most cases the presenting symptom was  related
o local invasion of the tumor [4]. These symptoms included jaun-
ice (most common), abdominal pain, pruritus, nausea, vomiting,
nd weight loss. These tumors are most commonly located in the
ommon hepatic duct, and distal common bile duct [10]. When a
atient is evaluated for a primary bile duct neoplasm, differentia-
ion between cholangiocarcinoma and an unusual bile duct tumor,
uch as a NET is very difﬁcult before surgical resection and histo-
ogic review. Percutaneous needle biopsies and endoscopic brush
iopsies are reliable only if they identify a malignancy [11]. Con-
equently NET are typically identiﬁed following surgical resection
s seen in the case presented. Of note, NETs are being diagnosed
t increasing frequency due to the growing number of endoscopies
erformed and to advances in our understanding and detection of
hese tumors [8].
Surgical resection is the corner stone of treatment for biliary
ET, and the only potential curative treatment [12,13]. Previously
eported patients who underwent curative resection had favorable
ong term disease free survival and long term survival, even in the
etting of metastatic liver disease [7]. Similar to NET located out-
ide the biliary tree the biologic behavior likely is related to the
egree of differentiation. NET can be classiﬁed using the World
ealth Organization (WHO) system that distinguishes between
ell-differentiated neuroendocrine tumors (NETs) and poorly dif-
erentiated neuroendocrine carcinomas (NECs) of small or large
ell type [5,6]. Well differentiated NETs, or carcinoid tumors, are
hose with mild or no atypia and are considered benign if they
o not demonstrate angioinvasion, are ≤1 cm in size, with ≤2
itoses/10HPFs. Tumors with low grade malignant potential are
1 cm,  mitotic index of >2 mitoses/10 HPFs, or proliferation index
2% Ki-67-positive cells. Poorly differentiated neuroendocrine car-
inomas (NECs) have high grade malignant potential, and are
omposed of highly atypical, small to intermediate-sized tumor
ells often with necrosis and prominent angio and/or perineural
nvasion.
The European Neuroendocrine Tumor Society (ENETS) is a sim-
ler classiﬁcation system proposing three categories (G1-3) that is
xclusively dependent upon the tumor’s proliferation status. In this
ystem, G1 tumors have <2 mitoses/10 HPFs, or a Ki-67 index less
han 2%. G2 tumors have 2–20 mitoses/10 HPFs, or a Ki-67 index
etween 3 and 20%. G3 tumors have >21 mitoses/10 HPFs, and a
i-67 index greater than 20%.PEN  ACCESS
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4. Conclusion
NET of the extrahepatic biliary tree are a rare entity. Typical
presentation is with painless jaundice and other symptoms related
to obstruction of the biliary tree. Surgical resection is the mainstay
of therapy, and the diagnosis is usually made post-operatively after
analysis by pathology.
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